CLINICAL TRIALS PROFILE FOR EPIDUO FORTE
⮫ Send this page by email
✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1 Remove trial restrictions
All Clinical Trials for Epiduo Forte
Trial ID
Title
Status
Sponsor
Phase
Start Date
Summary
NCT00658112 ↗
Measuring Adherence in Subjects With Acne Vulgaris in a Clinic Population Subtitle: Topical Benzoyl Peroxide for Acne
Completed
Wake Forest University
Phase 4
2006-07-01
The purpose of this research study is to see how often benzoyl peroxide is applied for acne.
Use of medication was monitored electronically.
NCT00757523 ↗
Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris
Completed
GlaxoSmithKline
Phase 4
2008-09-10
The purpose of this study is to compare the effectiveness of two marketed products in
subjects with facial acne vulgaris
NCT00757523 ↗
Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris
Completed
Stiefel, a GSK Company
Phase 4
2008-09-10
The purpose of this study is to compare the effectiveness of two marketed products in
subjects with facial acne vulgaris
NCT00907101 ↗
Evaluate Effectiveness of Epiduo® Gel in Reducing Antibiotic Sensitive & Resistant Strains of Propionibacterium (P)Acnes
Completed
Galderma Laboratories, L.P.
Phase 4
2009-06-01
The purpose of this study is to evaluate the effectiveness of Epiduo® Gel in reducing
antibiotic sensitive and resistant strains of P acnes in vivo.
NCT00919191 ↗
Evaluation of Irritation by Two Facial Gels Applied to Opposite Sides of the Face
Completed
Bausch Health Americas, Inc.
Phase 4
2009-04-01
A study to compare the skin irritation potential of two marketed gels for acne treatment,
each applied to half of the face of healthy volunteers.
>Trial ID
>Title
>Status
>Phase
>Start Date
>Summary
Clinical Trial Conditions for Epiduo Forte
Condition Name
Condition Name for Epiduo Forte
Intervention
Trials
Acne Vulgaris
22
Acne
8
Facial Acne
1
Local Adverse Effects
1
[disabled in preview]
0
This preview shows a limited data set
Subscribe for full access, or try a Trial
Condition MeSH
Condition MeSH for Epiduo Forte
Intervention
Trials
Acne Vulgaris
29
Hypersensitivity
1
[disabled in preview]
0
This preview shows a limited data set
Subscribe for full access, or try a Trial
Clinical Trial Locations for Epiduo Forte
Trials by Country
Trials by Country for Epiduo Forte
Location
Trials
United States
63
Canada
7
India
5
Germany
4
Poland
2
This preview shows a limited data set
Subscribe for full access, or try a Trial
Trials by US State
Trials by US State for Epiduo Forte
Location
Trials
Texas
6
North Carolina
6
Florida
5
California
4
Pennsylvania
4
This preview shows a limited data set
Subscribe for full access, or try a Trial
Clinical Trial Progress for Epiduo Forte
Clinical Trial Phase
Clinical Trial Phase for Epiduo Forte
Clinical Trial Phase
Trials
Phase 4
15
Phase 3
6
Phase 2
2
[disabled in preview]
5
This preview shows a limited data set
Subscribe for full access, or try a Trial
Clinical Trial Status
Clinical Trial Status for Epiduo Forte
Clinical Trial Phase
Trials
Completed
27
Recruiting
2
Unknown status
1
[disabled in preview]
1
This preview shows a limited data set
Subscribe for full access, or try a Trial
Clinical Trial Sponsors for Epiduo Forte
Sponsor Name
Sponsor Name for Epiduo Forte
Sponsor
Trials
Galderma
5
Galderma R&D
5
Galderma Laboratories, L.P.
5
[disabled in preview]
6
This preview shows a limited data set
Subscribe for full access, or try a Trial
Sponsor Type
Sponsor Type for Epiduo Forte
Sponsor
Trials
Industry
35
Other
9
[disabled in preview]
0
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.